This is the authors' abstract. We don't add key points for this paper.
Indium(III) iodide forms a 1:1 adduct with 9-xanthenone, of quasi-tetrahedral structure; triclinic, a = 10.805(4), b = 11.494(4), c = 7.493 (2) Å , α = 104.12(3), β = 106.35(3), γ = 91.165(3)°, V = 860.8(5) Å 3 , Z = 2, space group P1 - . With 9-fluorenone, the adduct has 1:2 stoichiometry, and approximately D 3h symmetry in the InI 3 O 2 kernel; the structure is triclinic, a =11.212(2), b = 16.504(3), c = 7.537(2) Å, α = 94.57(2), β = 109.05(1), γ = 91.165(15)°, V = 1312.6(4) Å 3 , Z = 2, space group P1 - . The solid structures, and the solution chemistry, are compared with those of related neutral derivatives of indium(III) halides.
No takes yet. Share an insight, caveat, or question.
Brown et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: